Natural Porcine Surfactant Augments Airway Inflammation after Allergen Challenge in Patients with Asthma

American Journal of Respiratory and Critical Care Medicine

Volumn 169, Issue 5, 2004, Pages 578-586

  Erpenbeck, Veit J ^b   Hagenberg, Andreas ^b   Dulkys, Yasmin ^b   Elsner, Jörn ^b   Bälder, Ralf ^b   Krentel, Harald ^b   Discher, Marc ^b   Braun, Armin ^b   Krug, Norbert ^b   Hohlfeld, Jens M ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b NONE

Author keywords

Allergy; Asthma; Immunomodulation; Pulmonary surfactant; Segmental allergen provocation

Indexed keywords

EOTAXIN; GAMMA INTERFERON; INTERLEUKIN 5; PORACTANT;

ADULT; ALLERGIC ASTHMA; ALLERGY TEST; ANTIGEN EXPRESSION; ARTICLE; BRONCHUS HYPERREACTIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; EOSINOPHIL; FEMALE; HUMAN; HYPEREOSINOPHILIA; IMMUNOMODULATION; LUNG LAVAGE; MALE; NEUTROPHIL CHEMOTAXIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN TRANSPORT; PROVOCATION TEST; TH1 CELL; TH2 CELL;

EID: 10744233278     PISSN: 00030805     EISSN: None     Source Type: Journal    
DOI: 10.1164/rccm.200301-104oc     Document Type: Article

References (40)

1. Liu M, Wang L, Holm BA, Enhorning G. Dysfunction of guinea-pig pulmonary surfactant and type II pneumocytes after repetitive challenge with aerosolized ovalbumin. Clin Exp Allergy 1997;27:802-807.
2. Hohlfeld JM, Ahlf K, Enhorning G, Balke K, Erpenbeck VJ, Petschallies J, Hoymann HG, Fabel H, Krug N. Dysfunction of pulmonary surfactant in asthmatics after segmental allergen challenge. Am J Respir Crit Care Med 1999;159:1803-1809.
3. Jarjour NN, Enhorning G. Antigen-induced airway inflammation in atopic subjects generates dysfunction of pulmonary surfactant. Am J Respir Crit Care Med 1999;160:336-341.
4. Wright SM, Hockey PM, Enhorning G, Strong P, Reid KB, Holgate ST, Djukanovic R, Postle AD. Altered airway surfactant phospholipid composition and reduced lung function in asthma. J Appl Physiol 2000;89:1283-1292.
5. Hohlfeld J, Fabel H, Hamm H. The role of pulmonary surfactant in obstructive airways disease. Eur Respir J 1997;10:482-491.
6. Becher G. Lung surfactant prevents allergic bronchial constriction in ovalbumin sensitized guinea pigs. Biomed Biochim Acta 1985;44:K57-K61.
7. Liu M, Wang L, Li E, Enhorning G. Pulmonary surfactant given prophylactically alleviates an asthma attack in guinea-pigs. Clin Exp Allergy 1996;26:270-275.
8. Kurashima K, Ogawa H, Ohka T, Fujimura M, Matsuda T, Kobayashi T. A pilot study of surfactant inhalation in the treatment of asthmatic attack. Arerugi 1991;40:160-163.
9. Oetomo SB, Dorrepaal C, Bos H, Gerritsen J, van der Mark TW, Koeter GH, van Aalderen WM. Surfactant nebulization does not alter airflow obstruction and bronchial responsiveness to histamine in asthmatic children. Am J Respir Crit Care Med 1996;153:1148-1152.
10. Babu KS, Woodcock DA, Smith SE, Staniforth JN, Holgate ST, Conway JH. Inhaled synthetic surfactant abolishes the early allergen-induced response in asthma. Eur Respir J 2003;21:1046-1049.
11. Djukanovic R, Roche WR, Wilson JW, Beasley CR, Twentyman OP, Howarth RH, Holgate ST. Mucosal inflammation in asthma. Am Rev Respir Dis 1990;142:434-457.
12. Strong P, Reid KB, Clark H. Intranasal delivery of a truncated recombinant human SP-D is effective at down-regulating allergic hypersensitivity in mice sensitized to allergens of Aspergillus fumigatus. Clin Exp Immunol 2002;130:19-24.
13. Madan T, Kishore U, Singh M, Strong P, Clark H, Hussain EM, Reid KB, Sarma PU. Surfactant proteins A and D protect mice against pulmonary hypersensitivity induced by Aspergillus fumigatus antigens and allergens. J Clin Invest 2001;107:467-475.
14. Wright JR. Immunomodulatory functions of surfactant. Physiol Rev 1997; 77:931-962.
15. Woerndle S, Bartmann P. The effect of three surfactant preparations on in vitro lymphocyte functions. J Perinat Med 1994;22:119-128.
16. Kremlev SG, Umstead TM, Phelps DS. Effects of surfactant protein A and surfactant lipids on lymphocyte proliferation in vitro. Am J Physiol 1994;267:L357-L364.
17. Tegtmeyer FK, Gortner L, Ludwig A, Brandt E. In vitro modulation of induced neutrophil activation by different surfactant preparations. Eur Respir J 1996;9:752-757.
18. Walti H, Polla BS, Bachelet M. Modified natural porcine surfactant inhibits superoxide anions and proinflammatory mediators released by resting and stimulated human monocytes. Pediatr Res 1997;41:114-119.
19. Baur FM, Brenner B, Goetze-Speer B, Neu S, Speer CP. Natural porcine surfactant (Curosurf) down-regulates mRNA of tumor necrosis factor-alpha (TNF-alpha) and TNF-alpha type II receptor in lipopolysaccharide-stimulated monocytes. Pediatr Res 1998;44:32-36.
20. Brenner B, Junge S, Birle A, Kadel S, Linderkamp O. Surfactant modulates intracellular signaling of the adhesion receptor L-selectin. Pediatr Res 2000;48:283-288.
21. Antal JM, Divis LT, Erzurum SC, Wiedemann HP, Thomassen MJ. Surfactant suppresses NF-kappa B activation in human monocytic cells. Am J Respir Cell Mol Biol 1996;14:374-379.
22. Bernhard W, Mottaghian J, Gebert A, Rau GA, von der Hardt H, Poets CF. Commercial versus native surfactants: surface activity, molecular components, and the effect of calcium. Am J Respir Crit Care Med 2000;162:1524-1533.
23. Krug N, Erpenbeck VJ, Balke K, Petschallies J, Tschernig T, Hohlfeld JM, Fabel H. Cytokine profile of bronchoalveolar lavage-derived CD4+, CD8+, and γδ T cells in people with asthma after segmental allergen challenge. Am J Respir Cell Mol Biol 2001;25:125-131.
24. Dulkys Y, Kluthe C, Buschermohle T, Barg I, Knoss S, Kapp A, Proudfoot AE, Elsner J. IL-3 induces down-regulation of CCR3 protein and mRNA in human eosinophils. J Immunol 2001;167:3443-3453.
25. Berner B, Akca D, Jung T, Muller GA, Reuss-Borst MA. Analysis of Th1 and Th2 cytokines expressing CD4+ and CD8+ T cells in rheumatoid arthritis by flow cytometry. J Rheumatol 2000;27:1128-1135.
26. Eisner J, Hochstetter R, Kimmig D, Kapp A. Human eotaxin represents a potent activator of the respiratory burst of human eosinophils. Eur J Immunol 1996;26:1919-1925.
27. Pataki G, Czopf L, Jilling T, Marczin N, Catravas J, Matalon S. Regulation of fluid-phase endocytosis in alveolar macrophages. Am J Physiol 1995;269:L520-L526.
28. McCormack FX, Whitsett JA. The pulmonary collectins, SP-A and SP-D, orchestrate innate immunity in the lung. J Clin Invest 2002;109:707-712.
29. Collins PD, Marleau S, Griffiths-Johnson DA, Jose PJ, Williams TJ. Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo. J Exp Med 1995;182:1169-1174.
30. Lamkhioued B, Renzi PM, Abi-Younes S, Garcia-Zepada EA, Allakhverdi Z, Ghaffar O, Rothenberg MD, Luster AD, Hamid Q. Increased expression of eotaxin in bronchoalveolar lavage and airways of asthmatics contributes to the chemotaxis of eosinophils to the site of inflammation. J Immunol 1997;159:4593-4601.
31. Kitaura M, Suzuki N, Imai T, Takagi S, Suzuki R, Nakajima T, Hirai K, Nomiyama H, Yoshie O. Molecular cloning of a novel human CC chemokine (Eotaxin-3) that is a functional ligand of CC chemokine receptor 3. J Biol Chem 1999;274:27975-27980.
32. Zimmermann N, Conkright JJ, Rothenberg ME. CC chemokine receptor-3 undergoes prolonged ligand-induced internalization. J Biol Chem 1999;274:12611-12618.
33. Elsner J, Mack M, Bruhl H, Dulkys Y, Kimmig D, Simmons G, Clapham PR, Schlondorff D, Kapp A, Wells TN, et al. Differential activation of CC chemokine receptors by AOP-RANTES. J Biol Chem 2000;275: 7787-7794.
34. Ogilvie P, Bardi G, Clark-Lewis I, Baggiolini M, Uguccioni M. Eotaxin is a natural antagonist for CCR2 and an agonist for CCR5. Blood 2001;97:1920-1924.
35. Borchers MT, Ansay T, DeSalle R, Daugherty BL, Shen H, Metzger M, Lee NA, Lee JJ. In vitro assessment of chemokine receptor-ligand interactions mediating mouse eosinophil migration. J Leukoc Biol 2002;71:1033-1041.
36. Schurch S, Gehr P, Im Hof V, Geiser M, Green F. Surfactant displaces particles toward the epithelium in airways and alveoli. Respir Physiol 1990;80:17-32.
37. Deslee G, Charbonnier AS, Hammad H, Angyalosi G, Tillie-Leblond I, Mantovani A, Tonnel AB, Pestel J. Involvement of the mannose receptor in the uptake of Der p 1, a major mite allergen, by human dendritic cells. J Allergy Clin Immunol 2002;110:763-770.
38. Moya FR, Hoffman DR, Zhao B, Johnston JM. Platelet-activating factor in surfactant preparations. Lancet 1993;341:858-860.
39. Christie PE, Henderson WR Jr. Lipid inflammatory mediators: leukotrienes, prostaglandins, platelet-activating factor. Clin Allergy Immunol 2002;16:233-254.
40. Wang JY, Shieh CC, You PF, Lei HY, Reid KB. Inhibitory effect of pulmonary surfactant proteins A and D on allergen-induced lymphocyte proliferation and histamine release in children with asthma. Am J Respir Crit Care Med 1998;158:510-518.